<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35726897</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2578-5745</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>ACR open rheumatology</Title><ISOAbbreviation>ACR Open Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Reply.</ArticleTitle><Pagination><StartPage>564</StartPage><EndPage>565</EndPage><MedlinePgn>564-565</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acr2.11476</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghavidel-Parsa</LastName><ForeName>Banafsheh</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9033-1756</Identifier><AffiliationInfo><Affiliation>Razi Hospital and School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidari</LastName><ForeName>Ali</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3583-1838</Identifier><AffiliationInfo><Affiliation>Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACR Open Rheumatol</MedlineTA><NlmUniqueID>101740025</NlmUniqueID><ISSNLinking>2578-5745</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>8</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35726897</ArticleId><ArticleId IdType="pmc">PMC9274343</ArticleId><ArticleId IdType="doi">10.1002/acr2.11476</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wolfe F, Rasker JJ, H&#xe4;user W. Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel&#x2010;Parsa et al. ACR Open Rheumatol 2022. E&#x2010;pub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9274344</ArticleId><ArticleId IdType="pubmed">35445583</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;user W, Br&#xe4;hler E, Ablin J, Wolfe F. Modified 2016 American College of Rheumatology fibromyalgia criteria, the analgesic, anesthetic, and addiction clinical trial translations innovations opportunities and networks&#x2010;American pain society pain taxonomy, and the prevalence of fibromyalgia. Arthritis Care Res (Hoboken) 2021;73:617&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">32248629</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg DL. Diagnosing fibromyalgia as a disease, an illness, a state, or a trait? [editorial]. Arthritis Care Res (Hoboken) 2019;71:334&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30724034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Br&#xe4;hler E, Hinz A, H&#xe4;user W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 2013;65:777&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">23424058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidari A, Ghavidel&#x2010;Parsa B, Ghalehbaghi B. Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6&#x2010;month prospective cohort study. Mod Rheumatol 2009;19:663&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19730972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Rasker JJ. The evolution of fibromyalgia, its concepts, and criteria. Cureus 2021;13:e20010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8716007</ArticleId><ArticleId IdType="pubmed">34987901</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>